section name header

Basics

Pathogenesis

Clinical Manifestations

Diagnosis

Diagnosis-icon.jpg Differential Diagnosis

Other Viral Exanthems
  • Vesicular exanthems of coxsackievirus and echovirus infections may be mistaken for varicella.

  • These exanthems may show a characteristic distribution, as in hand-foot-and-mouth disease.

Eczema Herpeticum (Kaposi Varicelliform Eruption, see Fig. 4.13)
  • Atopic dermatitis that becomes secondarily infected with HSV.

  • Direct immunofluorescence or culture results indicative of HSV infection.

Management-icon.jpg Management

Acute Varicella
  • Uncomplicated varicella in otherwise healthy children is usually a mild self-limited disease and is generally treated with supportive care such as antipruritics and antipyretics. Aspirin should be avoided because of the risk of Reye syndrome.

  • Oral acyclovir is warranted in patients who are at an increased risk of complications, and, in general, it should be started within 24 hours of the onset of the rash.

These patients include the following:

  • Otherwise healthy, nonpregnant patients 13 years of age or older.

  • Children older than 12 months of age with chronic skin or pulmonary conditions.

  • Children receiving chronic corticosteroids or salicylates.

  • Intravenous acyclovir is indicated in immunocompromised patients or in patients with virally mediated complications of varicella.

  • Varicella-zoster immune globulin (VariZIG) or the varicella vaccine can be given prophylactically to immunocompromised individuals with known exposure to VZV.

Varicella Vaccine
  • The VZV vaccine is recommended for universal immunization in all children.

  • Given the occurrence of breakthrough varicella with the one dose regimen, the current recommendation is for a two-dose VZV vaccine schedule. Initial dose is optimally given between 12 and 18 months of age; and a booster immunization should be given between 4 and 6 years of age.

  • However, the vaccine may be administered at any time before 13 years of age as two doses given at least 3 months apart.

  • Unimmunized older adolescents or adults should receive two doses of the vaccine administered at least 28 days apart.

Varicella and Pregnancy
  • Peripartal maternal varicella poses a particular risk to the newborn. Neonates born 2 days before or 5 days after the onset of maternal varicella should be given varicella immunoglobulin (VZIG). Newborns who develop varicella should be treated with intravenous acyclovir.

  • Oral acyclovir is not recommended in pregnant women with uncomplicated varicella because the risks and benefits to the fetus are unknown.

Helpful-Hint-icon.jpg Helpful Hints

  • In the United States, two varicella-containing vaccines are licensed for use—Varivax, a monovalent vaccine and ProQuad, which combines varicella and measles-mumps-rubella virus (MMRV). When possible the combination should be used to decrease the number of injections.

  • Children can still get herpes zoster after VZV immunization, although the risk seems to be lower than after wild-type varicella infection.

Point-Remember-icon.jpg Point to Remember

  • Patients with chickenpox remain contagious until all cutaneous lesions are crusted.

Other Information

Complications